 Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores
Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores
Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores
Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26
GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26 The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore
The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore 
              The Operations Committee of the Board of Directors of Glenmark Pharmaceuticals Ltd, at its Meeting held on July 14, 2016 allotted 2,000 equity shares to the employee of the Company on exercise of options granted to them pursuant to ESOS 2003.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.853.25 as compared to the previous close of Rs. 848.6. The total number of shares traded during the day was 40663 in over 1575 trades.
The stock hit an intraday high of Rs. 858 and intraday low of 846. The net turnover during the day was Rs. 34691922.